Clinical trial
ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss
NCT02518685 · BaroNova, Inc., Industry · Completed
Key facts
| NCT number | NCT02518685 |
|---|---|
| Title | ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss |
| Official title | Endoscopic Treatment for Weight Reduction in Patients With Obesity Using the TransPyloric Shuttle® System: A Multicenter, Prospective, Randomized, Double-Blind, Sham-Controlled, Parallel-Design Study |
| Lead sponsor | BaroNova, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Behavioral, Device |
| Interventions | TransPyloric Shuttle, Sham procedure, Lifestyle Counseling |
| Enrollment | 302 |
| Start date | Sep 1, 2015 |
| Primary completion | Dec 1, 2017 |
| Completion | Mar 1, 2018 |
| First posted | Aug 10, 2015 |
| Last update posted | Jul 17, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: